Create 8 slide presentation with speaker notes about a selected disease process and drug class. The presentation should provide content specific information on the selected disease process and drug class for staff or students in a clinical environment.

For this presentation, I’ve chosen the illness technique of Kind 2 Diabetes and the drug class of DPP-4 inhibitors.

Slide 1: Introduction

• Introduce the subject of the presentation
• Spotlight the important thing factors that might be lined

Slide 2: Illness Course of Overview

• Present a quick overview of Kind 2 Diabetes
• Focus on the pathophysiology of the illness course of

Slide 3: Drug Class Overview

• Focus on DPP-4 inhibitors and their mechanism of motion
• Describe how they work within the physique

Slide 4: Pharmacokinetics and Pharmacodynamics

• Focus on how DPP-4 inhibitors are metabolized and excreted
• Clarify the connection between DPP-4 inhibitors and blood glucose management

Slide 5: Product Description and Meant Use

• Describe the various kinds of DPP-4 inhibitors out there
• Focus on the meant use of DPP-4 inhibitors within the administration of Kind 2 Diabetes

Slide 6: Facet Results and Opposed Reactions

• Record widespread uncomfortable side effects of DPP-4 inhibitors
• Focus on potential adversarial reactions and questions of safety related to DPP-4 inhibitors

Slide 7: Ethnic, Cultural, and Genetic Variations

• Focus on how variations in ethnicity, tradition, and genetics can have an effect on the protection and efficacy of DPP-4 inhibitors
• Present examples of populations which may be affected

Slide 8: Monitoring and Observe-Up

• Clarify methods to monitor the effectiveness of DPP-4 inhibitors in managing Kind 2 Diabetes
• Focus on the significance of standard follow-up appointments with healthcare suppliers

References:

1. American Diabetes Affiliation. (2021). Requirements of Medical Care in Diabetes—2021 Abridged for Major Care Suppliers. Scientific Diabetes, 39(1), 4-9.
2. Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., … & Garvey, W. T. (2018). Consensus assertion by the American Affiliation of Scientific Endocrinologists and American Faculty of Endocrinology on the great sort 2 diabetes administration algorithm–2018 government abstract. Endocrine follow, 24(1), 91-120.
3. Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., … & Matthews, D. R. (2015). Administration of hyperglycemia in sort 2 diabetes, 2015: a patient-centered strategy: replace to a place assertion of the American Diabetes Affiliation and the European Affiliation for the Examine of Diabetes. Diabetes care, 38(1), 140-149.